Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

The expression of S100A4 protein in human intrahepatic cholangiocarcinoma: clinicopathologic significance and prognostic value.

Tian X, Wang Q, Li Y, Hu J, Wu L, Ding Q, Zhang C.

Pathol Oncol Res. 2015 Jan;21(1):195-201. doi: 10.1007/s12253-014-9806-6. Epub 2014 Jul 2.

PMID:
24985031
3.

Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma.

Xu Y, Zhu M, Zhang S, Liu H, Li T, Qin C.

Pathol Oncol Res. 2010 Jun;16(2):169-75. doi: 10.1007/s12253-009-9200-y. Epub 2009 Sep 9.

PMID:
19757198
4.

Expression of matrix metalloproteinase 2 and extracellular matrix metalloproteinase inducer are unfavorable postoperative prognostic factors in intrahepatic cholangiocarcinoma.

Zhang C, Tu Z, Du S, Wang Y, Wang Q.

Pathol Oncol Res. 2010 Mar;16(1):47-53. doi: 10.1007/s12253-009-9186-5. Epub 2009 Jul 25.

PMID:
19629755
5.

Nuclear expression of S100A4 calcium-binding protein increases cholangiocarcinoma invasiveness and metastasization.

Fabris L, Cadamuro M, Moserle L, Dziura J, Cong X, Sambado L, Nardo G, Sonzogni A, Colledan M, Furlanetto A, Bassi N, Massani M, Cillo U, Mescoli C, Indraccolo S, Rugge M, Okolicsanyi L, Strazzabosco M.

Hepatology. 2011 Sep 2;54(3):890-9. doi: 10.1002/hep.24466.

6.

Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications.

Zhang C, Liu LX, Dong ZR, Shi GM, Cai JB, Zhang PF, Ke AW, Yu JX, Zhou J, Fan J.

Tumour Biol. 2015 Mar;36(3):1781-9. doi: 10.1007/s13277-014-2780-5. Epub 2014 Nov 13.

PMID:
25391422
7.

High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery.

Shi RY, Yang XR, Shen QJ, Yang LX, Xu Y, Qiu SJ, Sun YF, Zhang X, Wang Z, Zhu K, Qin WX, Tang ZY, Fan J, Zhou J.

Cancer. 2013 Mar 1;119(5):993-1003. doi: 10.1002/cncr.27788. Epub 2012 Nov 6.

8.

ZEB1 expression is associated with prognosis of intrahepatic cholangiocarcinoma.

Terashita K, Chuma M, Hatanaka Y, Hatanaka K, Mitsuhashi T, Yokoo H, Ohmura T, Ishizu H, Muraoka S, Nagasaka A, Tsuji T, Yamamoto Y, Kurauchi N, Shimoyama N, Toyoda H, Kumada T, Kaneoka Y, Maeda A, Ogawa K, Natsuizaka M, Kamachi H, Kakisaka T, Kamiyama T, Taketomi A, Matsuno Y, Sakamoto N.

J Clin Pathol. 2016 Jul;69(7):593-9. doi: 10.1136/jclinpath-2015-203115. Epub 2015 Dec 15.

PMID:
26670746
9.

S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.

Zhao Y, Zhang T, Wang Q.

Oncol Rep. 2013 Jul;30(1):111-8. doi: 10.3892/or.2013.2419. Epub 2013 Apr 23.

PMID:
23612849
10.

Clinicopathologic significance of slug expression in human intrahepatic cholangiocarcinoma.

Zhang KJ, Zhang BY, Zhang KP, Tang LM, Liu SS, Zhu DM, Zhang DL.

World J Gastroenterol. 2010 May 28;16(20):2554-7.

11.

Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma.

Kubo Y, Aishima S, Tanaka Y, Shindo K, Mizuuchi Y, Abe K, Shirabe K, Maehara Y, Honda H, Oda Y.

Hum Pathol. 2014 Aug;45(8):1610-7. doi: 10.1016/j.humpath.2014.03.008. Epub 2014 Apr 4.

PMID:
24824030
12.

Lymphatic spread is related to VEGF-C expression and D2-40-positive myofibroblasts in intrahepatic cholangiocarcinoma.

Aishima S, Nishihara Y, Iguchi T, Taguchi K, Taketomi A, Maehara Y, Tsuneyoshi M.

Mod Pathol. 2008 Mar;21(3):256-64. doi: 10.1038/modpathol.3800985. Epub 2008 Jan 11.

13.

The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.

Wang Y, Wan M, Zhou Q, Wang H, Wang Z, Zhong X, Zhang L, Tai S, Cui Y.

PLoS One. 2015 Oct 20;10(10):e0141165. doi: 10.1371/journal.pone.0141165. eCollection 2015.

14.

High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.

Xu YF, Ge FJ, Han B, Yang XQ, Su H, Zhao AC, Zhao MH, Yang YB, Yang J.

World J Gastroenterol. 2015 Mar 21;21(11):3256-65. doi: 10.3748/wjg.v21.i11.3256.

15.

EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.

Hao XY, Cai JP, Liu X, Chen W, Hou X, Chen D, Lai JM, Liang LJ, Yin XY.

Chin J Cancer. 2016 Jul 28;35(1):70. doi: 10.1186/s40880-016-0133-z.

16.

CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.

Su MC, Hsu C, Kao HL, Jeng YM.

Cancer Lett. 2006 Apr 8;235(1):34-9. Epub 2005 Aug 25.

PMID:
16125303
17.

Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.

Aishima S, Kuroda Y, Nishihara Y, Taguchi K, Iguchi T, Taketomi A, Maehara Y, Tsuneyoshi M.

Hum Pathol. 2007 Dec;38(12):1819-25. Epub 2007 Sep 14.

PMID:
17854859
18.

Identification of Homer1 as a potential prognostic marker for intrahepatic cholangiocarcinoma.

Wu SY, Yu MX, Li XG, Xu SF, Shen J, Sun Z, Zhou X, Chen XZ, Tu JC.

Asian Pac J Cancer Prev. 2014;15(7):3299-304.

19.

Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts.

Itatsu K, Zen Y, Yamaguchi J, Ohira S, Ishikawa A, Ikeda H, Sato Y, Harada K, Sasaki M, Sasaki M, Sakamoto H, Nagino M, Nimura Y, Ohta T, Nakanuma Y.

Hum Pathol. 2008 May;39(5):710-9. doi: 10.1016/j.humpath.2007.09.016. Epub 2008 Mar 10.

PMID:
18329694
20.

Expression of matrix metalloproteinase-7 is an unfavorable prognostic factor in intrahepatic cholangiocarcinoma.

Hirashita T, Iwashita Y, Ohta M, Komori Y, Eguchi H, Yada K, Kitano S.

J Gastrointest Surg. 2012 Apr;16(4):842-8. doi: 10.1007/s11605-011-1813-2. Epub 2012 Jan 13.

Supplemental Content

Support Center